<DOC>
	<DOCNO>NCT02890030</DOCNO>
	<brief_summary>The patient enrol new study serve appropriate comparison group consist patient diagnosis germ cell testicular cancer cure surgical resection receive cisplatin-based chemotherapy group patient another study receive cisplatin-based chemotherapy .</brief_summary>
	<brief_title>The Platinum Study Comparison Group</brief_title>
	<detailed_description>Primary Objective To compare prevalence ototoxicity neurotoxicity GCT cancer survivor surgery similar population The Platinum Study ( RSRB45410/1305011509 ) receive cisplatin-based combination chemotherapy . Secondary Objective To compare prevalence obesity , hypertension , use antidepressants/anxiolytics GCT cancer survivor surgery similar population The Platinum Study receive cisplatin-based combination chemotherapy .</detailed_description>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<criteria>Diagnosis confirmation diagnosis histologically serologically confirm testicular germ cell tumor ( GCT ) GCT another anatomic location Age GCT diagnosis : 55 year age young Males , 18 year age old time study consent Subject able provide consent Subject able speak read English Treatment consist surgery ( i.e. , orchiectomy and/or retroperitoneal lymph node dissection [ RPLND ] ) either initial testicular germ cell tumor ( GCT ) subsequent testicular cancer Subject complete surgery &gt; 1 year ago Subject currently undergo active followup IU Subject require subsequent chemotherapy , salvage chemotherapy treatment bone marrow transplant . Subject prior chemotherapy kind Patients prior chemotherapy ( whether GCT cancer )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Cisplatin-based therapy</keyword>
	<keyword>Ototoxicity</keyword>
	<keyword>Neurotoxicity</keyword>
</DOC>